Similar effects were observed for other cytotoxic drugs in NSCLC cells displaying a synergistic interaction with gefitinib, as well as with the TS-inhibitor 5-fluorouracil (5-FU) in colorectal cancer cells (Van Schaeybroeck et al, 2005, 2006). This evidence concerns the gene TYMS and colorectal cancer.